Thank you for contacting ReportLinker. From our many reports, we have selected four that we hope will help with your query.
The first report is titled Pharmaceuticals: Global Group of Eight Industry Guide. Published by Marketline in January 2016. this 189 page study looks at the pharmaceutical industry for the G8 nations; The USA, Canada, Germany, France, The UK, Italy, Russia and Japan. It found that G8 countries contributed $554.1 billion to the global pharmaceuticals industry in 2014, with a compound annual growth rate of 3.3% between 2010 and 2014. The US leads the group, with revenues of $303.9 billion, with Japan and Germany following at $85.5 billion and $37.1 billion respectively. This report looks into the size growth and leading players both in the G8 market as a whole and individually. It uses a five forces analysis to analyze the competitive intensity and attractiveness of the market.
The next study was also published by Marketline in January 2016. Pharmaceuticals: BRIC (Brazil, Russia, India, China) Industry Guide is a 110 page report that looks at the market share, market size, leading players and key financial metrics of the market. It looks at historical data from 2010-2014 and also makes predictions to 2019. The total market value for these four countries was $148.2 billion in 2014. China was the fastest growing country, with a compound annual growth rate of 18.7% over the 2010-2014 period.
Another report by Marketline covers the strongest emerging markets. Pharmaceuticals: Top 5 Emerging Markets Industry Guide is a 140 page study published in January 2016. This report looks at and compares data from Brazil, China, India, Mexico and South Africa. This report also covers the leading players, competitive pressures, key financial metrics, market size and market share. Together, pharmaceutical industry in these countries had revenues of $144.6 billion in 2014 after having a compound annual growth rate of 15.6% between 2010 and 2011. The compound annual growth rate is expected to stay high, at a rate of 13.3% from 2014 to 2019 with the market value for these countries expected to be $269.9 billion in 2019.
The last report is Pharmaceutical Industry in the United States. Published by Aruvian’s Research in March 2016, this 175 page report looks at how the industry is globalizing and being dominated by multinational companies. The industry has seen significant change over recent decades, with the rise of the biotechnology sector, growth in demand driven demographics and increased competition. It is being increasingly scrutinized due to the high expenditure on drugs in the united states, growing at about 15% per year. This report conducts a PEST analysis and a Porter’s Five Forces analysis, to help readers find the best strategies in the market.
We hope this information has been helpful to you. There is a lot of useful information about the healthcare industry in ReportLinker’s portal. If you have any questions or further needs, please feel free to contact us.